Guest guest Posted January 21, 2006 Report Share Posted January 21, 2006 Did anyone see this MSNews article that came out yesterday: " Antibodies to myelin proteins have been found in MS lesions and are thought to be somehow involved in MS disease activity. However, it's unclear exactly what role they play in causing or furthering myelin damage in MS. A team of researchers recently posted an interesting paper (free public access!) exploring this question further. They isolated serum antibodies to myelin basic protein (MBP) from MS subjects, non-MS controls, and EAE mice and analyzed their effects on MBP proteins. They found that the antibodies from MS subjects and EAE mice (but not the controls) were actually able to cleave, or break, the MBP chains, leading to degradation of the protein. Additional tests were done to make sure this cleavage could be attributed to the antibodies and not some other factor present in the assay, to see which sites within the MBP chains were targeted for cleavage, and to determine what types of biochemical pathways were involved in the degradation. The researchers also discovered that Copaxone was able to block the antibodies and prevent them from binding to MBP, thus preventing the damage. This study represents progress in the understanding of how damage is caused in MS, and leads to new lines of research such as the development of other treatments which (like Copaxone) can block the activity of destructive auto antibodies in MS. " I'm thinking maybe we should think twice before stopping Copaxone... Interesting, huh? Rae Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.